Eisai Inc.
15 drugs in NADAC|0 Generic,15 Brand
Eisai Inc. lists 15 NDCs in the CMS NADAC file (0 generic, 15 brand), at an average NADAC of $22.09 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
15
0G / 15B
Avg Price / Unit
$22.0941
$3.65 – $39.14
Avg 7d Change
+0.01%
Across 9 drugs with changes
7d Activity
of 15 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
perampanel market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Noncompetitive AMPA Glutamate Receptor Antagonist therapeutic class
Review the broader class where Eisai Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Eisai Inc. make?
Eisai Inc. lists 15 NDCs in the CMS NADAC file — 0 generic and 15 brand products.
What is the average price of Eisai Inc. drugs?
The average NADAC across Eisai Inc.'s portfolio is $22.0941 per unit, ranging from $3.6487 to $39.1403.
What types of drugs does Eisai Inc. make?
Eisai Inc. makes drugs across 3 FDA pharmacologic classes. The most common by NDC count are Noncompetitive AMPA Glutamate Receptor Antagonist (7), Cholinesterase Inhibitor (3), Orexin Receptor Antagonist (2).
Has Eisai Inc. had any drug recalls?
No FDA enforcement recalls are matched to Eisai Inc. in the openFDA feed.
How has Eisai Inc.'s pricing changed recently?
Over the past 7 days, 5 Eisai Inc. products rose and 4 fell, with a portfolio-wide average change of +0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FYCOMPA 4 MG TABLET perampanel | $39.1403 per EA | +0.12% |
FYCOMPA 6 MG TABLET perampanel | $39.1334 per EA | +0.01% |
FYCOMPA 10 MG TABLET perampanel | $39.1155 per EA | +0.05% |
FYCOMPA 12 MG TABLET perampanel | $39.1096 per EA | +0.08% |
FYCOMPA 8 MG TABLET perampanel | $39.0872 per EA | -0.05% |
BANZEL 400 MG TABLET rufinamide | $25.1826 per EA | -0.05% |
FYCOMPA 2 MG TABLET perampanel | $19.7543 per EA | +0.07% |
ARICEPT 5 MG TABLET donepezil hydrochloride | $16.4368 per EA | — |
ARICEPT 10 MG TABLET donepezil hydrochloride | $16.1969 per EA | — |
ARICEPT 23 MG TABLET donepezil hydrochloride | $14.3864 per EA | — |
BANZEL 200 MG TABLET rufinamide | $12.6103 per EA | — |
DAYVIGO 5 MG TABLET lemborexant | $11.5776 per EA | -0.02% |
DAYVIGO 10 MG TABLET lemborexant | $11.5670 per EA | -0.11% |
FYCOMPA 0.5 MG/ML ORAL SUSP perampanel | $4.4642 per ML | — |
BANZEL 40 MG/ML SUSPENSION rufinamide | $3.6487 per ML | 0.00% |